Bryan M. Reasons insider trades
Open-market stock purchases and sales by Bryan M. Reasons, EVP & CFO at Mallinckrodt plc, from SEC Form 4 filings since Oct 26, 2012.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- NONE Mallinckrodt plc: other filings, last Jan 1, 2025
- ACRS Aclaris Therapeutics, Inc: other filings, last Jun 1, 2024
- SCTL Societal CDMO, Inc: 1 buy, last Apr 8, 2024
- MNKTQ Mallinckrodt plc: other filings, last Nov 14, 2023
- MNK Mallinckrodt plc: 1 buy, last Aug 17, 2023
- MNKPF Mallinckrodt plc: other filings, last Jun 16, 2022
- REPH Recro Pharma, Inc: other filings, last Apr 20, 2021
- MNKKQ Mallinckrodt plc: 1 sale, last Dec 3, 2020
- AMRX Amneal Pharmaceuticals, Inc: 1 sale, last Aug 21, 2018
- IPXL Impax Laboratories, LLC: other filings, last May 4, 2018